Genome editing with programmable site-specific nucleases

Uirusu
Takashi YamamotoTetsushi Sakuma

Abstract

Genome editing is a cutting-edge technology that enables to modify the target gene using programmable site-specific nucleases, such as TALENs and CRISPR/Cas9. Currently, cell and animal models of human diseases have been competitively created throughout the world, because genome editing technology paved the way for genetic modifications even in cells and organisms that had been difficult to manipulate the genome. In this review, we introduce the basic principles and current situations of genome editing with programmable nucleases.

References

Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y G KimS Chandrasegaran
May 27, 2008·Nature Biotechnology·Xiangdong MengScot A Wolfe
Jul 25, 2009·Science·Aron M GeurtsRoland Buelow
Dec 3, 2009·Genome Research·Hyung Joo LeeJin-Soo Kim
Feb 18, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Thomas J CradickAnton P McCaffrey
Jul 19, 2011·Nature Methods·Fuqiang ChenGregory D Davis
Jan 10, 2012·Science·Amanda Nga-Sze MakBarry L Stoddard
Jun 5, 2012·Proceedings of the National Academy of Sciences of the United States of America·Melanie MeyerRalf Kühn
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Dec 19, 2012·Cell Stem Cell·Qiurong DingChad A Cowan
Feb 8, 2013·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Tetsushi SakumaTakashi Yamamoto
Mar 13, 2013·Genome Research·Ankit GuptaScot A Wolfe
Apr 10, 2013·Genome Research·Marion PiganeauErika Brunet
Jun 25, 2013·Nature Biotechnology·Yanfang FuJeffry D Sander
Jul 23, 2013·Nature Biotechnology·Patrick D HsuFeng Zhang
Jul 26, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kristie BloomPatrick Arbuthnot
Aug 27, 2013·Scientific Reports·Hirotaka EbinaYoshio Koyanagi
Sep 3, 2013·Nucleic Acids Research·Wataru FujiiKunihiko Naito
Oct 3, 2013·Blood·Xavier M AnguelaKatherine A High
Nov 30, 2013·Scientific Reports·Tetsushi SakumaTakashi Yamamoto
Feb 14, 2014·Experimental Animals·Yoshiko NakagawaTetsushi Sakuma
Mar 4, 2014·Nature Biotechnology·Jeffry D Sander, J Keith Joung
Mar 19, 2014·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Daisuke TokumasuTakashi Yamamoto
Apr 1, 2014·Nature Biotechnology·Hao YinDaniel G Anderson

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.